# Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

> **NCT03652623** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hektoen Institute for Medical Research** · enrollment: 49 (actual)

## Conditions studied

- HIV/AIDS
- Gender
- Behavior and Behavior Mechanisms

## Interventions

- **DRUG:** TDF/FTC

## Key facts

- **NCT ID:** NCT03652623
- **Lead sponsor:** Hektoen Institute for Medical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-23
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652623, "Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03652623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*